Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-058033
Filing Date
2022-02-28
Accepted
2022-02-28 16:36:07
Documents
6
Effectiveness Date
2022-02-28

Document Format Files

Seq Description Document Type Size
1 S-8 d152492ds8.htm S-8 39452
2 EX-5.1 d152492dex51.htm EX-5.1 8899
3 EX-23.1 d152492dex231.htm EX-23.1 1695
4 EX-FILING FEES d152492dexfilingfees.htm EX-FILING FEES 21328
5 GRAPHIC g152492dsp9a.jpg GRAPHIC 7599
6 GRAPHIC g152492g0225102403931.jpg GRAPHIC 1649
  Complete submission text file 0001193125-22-058033.txt   85456
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263088 | Film No.: 22690380
SIC: 2836 Biological Products, (No Diagnostic Substances)